tiprankstipranks
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN

BioMarin Pharmaceutical (BMRN) Financial Statements

1,773 Followers

BioMarin Pharmaceutical Financial Overview

BioMarin Pharmaceutical's market cap is currently ―. The company's EPS TTM is $0.871; its P/E ratio is 100.71; BioMarin Pharmaceutical is scheduled to report earnings on April 24, 2024, and the estimated EPS forecast is $0.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 646.21M$ 581.33M$ 584.70M$ 596.41M$ 537.54M
Gross Profit$ 510.73M$ 456.58M$ 482.82M$ 454.20M$ 410.25M
EBIT$ 25.43M$ 45.45M$ 74.56M$ 60.46M$ -14.53M
EBITDA$ 50.83M$ 70.03M$ 98.45M$ 85.94M$ 10.03M
Net Income Common Stockholders$ -73.58M$ 71.74M$ 56.04M$ 50.85M$ -249.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.07B$ 1.13B$ 1.17B$ 1.15B$ 1.29B
Total Assets$ 6.84B$ 6.76B$ 6.56B$ 6.43B$ 6.38B
Total Debt$ 1.09B$ 1.09B$ 1.08B$ 1.08B$ 1.09B
Net Debt$ 13.16M$ -39.86M$ -85.96M$ -68.08M$ -198.14M
Total Liabilities$ 1.89B$ 1.86B$ 1.78B$ 1.77B$ 1.77B
Stockholders Equity$ 4.95B$ 4.90B$ 4.78B$ 4.66B$ 4.60B
Cash Flow-
Free Cash Flow$ -9.21M$ 112.23M$ 47.38M$ -98.75M$ -29.57M
Operating Cash Flow$ 27.48M$ 135.65M$ 70.11M$ -73.98M$ 6.79M
Investing Cash Flow$ -64.96M$ -45.80M$ 29.53M$ -30.01M$ -54.71M
Financing Cash Flow$ 10.84M$ -788.00K$ 11.96M$ -40.74M$ 10.87M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History

BioMarin Pharmaceutical Debt to Assets

BioMarin Pharmaceutical Cash Flow

BioMarin Pharmaceutical Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis